Skip to Content

Tag: Fisher & Paykel Healthcare


Lewis Gradon

Vendors

F&P sees increased demand due to COVID-19 surges 

January 22, 2021HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare reports operating revenue for the nine months ended Dec. 31, 2020, was up 73% in constant currency compared to the prior comparable period.  In the hospital product group, operating revenue was up 113%, with hardware growing 446% and consumables growing 54%.  “In many parts of the world, we have continued to see an influx of COVID-19 patients requiring hospitalization for respiratory treatment,” said Lewis Gradon,...

coronavirus outbreak, financial results, Fisher & Paykel Healthcare, nasal high flow therapy, osa, sleep therapy


Read Full Articlered right arrow icon

Also Noted

F&P Healthcare wins ‘people’s choice’ award 

January 5, 2021HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare was honored to win a Zenith Award from the American Association for Respiratory Care for the sixth year in a row. The Zenith Awards are considered the “people’s choice” awards of the respiratory care profession, because its recipients are chosen by more than 47,000 respiratory therapists. “We’d like to thank the thousands of respiratory care professionals who are caring for patients during the COVID-19 pandemic...

American Association for Respiratory Care, Fisher & Paykel Healthcare, Zenith Award


Read Full Articlered right arrow icon

Lewis Gradon

Also Noted

F&P Healthcare named ‘standout winner’ 

January 4, 2021HME News Staff

AUCKLAND, New Zealand – Fisher & Paykel Healthcare was named Company of the Year and its CEO Lewis Gradon was named Chief Executive of the Year in the Deloitte Top 200 Awards sponsored by Deloitte, the New Zealand Herald and New Zealand Media and Entertainment. Judging for the Company of the Year award included the latest financial measures, organizational performance, corporate reputation and approach to environmental management. Judges recognized F&P for its response to the COVID-19 pandemic,...

Deloitte Top 200 Awards, Fisher & Paykel Healthcare, Lewis Gradon


Read Full Articlered right arrow icon

Vendors

F&P's first half: Stability and variability, all at the same time

December 3, 2020Liz Beaulieu, Editor

LAGUNA HILLS, Calif. - Fisher & Paykel Healthcare reported stable operating revenue for its homecare products group in the first half of the 2021 financial year, despite many sleep labs closing or operating at reduced capacity due to the COVID-19 pandemic. The company reported $226.2 million in operating revenue for the group, which includes products used to treat obstructive sleep apnea in the home, a 5% increase compared to the same period in the previous financial year. “The...

coronavirus outbreak, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

F&P Healthcare tracks 'surge'

December 1, 2020HME News Staff

LAGUNA HILLS, Calif. - Fisher & Paykel Healthcare reported operating revenue of $226.2 million for the first half of the 2021 financial year for its homecare product group, a 5% increase compared to the same period in the previous financial year. “Since the pandemic started, many sleep clinics have been closed, resulting in a reduction in new patient diagnoses,” said Lewis Gradon, managing director and CEO. “Our F&P Evora and F&P Vitera masks for OSA are great products that...

financial results, Fisher & Paykel Healthcare, respiratory products


Read Full Articlered right arrow icon

Also Noted

F&P launches mask setup app

August 28, 2020HME News Staff

IRVINE, Calif. - Fisher & Paykel Healthcare has launched the F&P myMask, an app to guide obstructive sleep apnea patients who are new to CPAP therapy through the mask setup process. Step-by-step videos guide patients through mask fitting, fine-tuning, cleaning and assembly, offering easy access to instructions and support, and complementing the care of the health care provider. The F&P myMask app is now available in the USA on iOS and Android devices with the following masks: Evora, Vitera, Simplus,...

CPAP mask, F&P myMask, Fisher & Paykel Healthcare, sleep apnea


Read Full Articlered right arrow icon

Also Noted

F&P plans for 3rd manufacturing facility in Mexico

August 21, 2020HME News Staff

IRVINE, Calif. - Fisher & Paykel Healthcare has started planning for its third manufacturing facility in Mexico. “We are continuing to grow our manufacturing capacity to ensure a further increase in supply of our respiratory products is available if required,” said Lewis Gradon, director and CEO. “To expedite availability, the company is utilizing its existing infrastructure and property in Tijuana, Mexico.” The company says the facility will be commissioned within the next...

expansion, Fisher & Paykel Healthcare, manufacturing, respiratory


Read Full Articlered right arrow icon

Vendors

F&P's Evora: A mask fit for the times

August 3, 2020Liz Beaulieu, Editor

IRVINE, Calif. - Launching a product in the middle of a global pandemic is a challenge, but Fisher & Paykel Healthcare believes its new mask has a number of features that makes it an easier sell for HME providers and users.The company announced in July that the F&P Evora, a nasal mask with what it calls “CapFit” headgear, which allows users to put on their masks like a baseball cap, had received regulatory clearance for use in the United States.“Given the current situation and the...

CPAP mask, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

F&P's nasal high flow therapy in spotlight

July 2, 2020Liz Beaulieu, Editor

IRVINE, Calif. - Fisher & Paykel Healthcare's Optiflow nasal high flow therapy has gained traction as a preferred treatment for COVID-19, as hospitals move away from an “early intubation and mechanical ventilation” mentality, company officials say.“As this pandemic has evolved, nasal high flow therapy, and in particular our Optiflow system, has steadily gained increasing acceptance,” said Lewis Gradon, managing director and CEO during a recent call to discuss the company's...

Fisher & Paykel Healthcare, Optiflow


Read Full Articlered right arrow icon

Vendors

F&P's homecare group sees 9% increase in revenues

June 30, 2020HME News Staff

IRVINE, Calif. - Fisher & Paykel Healthcare reported operating revenue of $1.26 billion for its fiscal year ended March 31, 2020, an 18% increase compared to 2019 or a 14% increase in constant currency.It reported net profit after tax of $287.3 million, a 37% increase in 2020 vs. 2019 or 30% in constant currency.The increase in revenue was largely driven by growth in the use of F&P's Optiflow nasal high flow therapy, demand for products to treat COVID-19 patients and strong hospital hardware sales...

financial results, Fisher & Paykel Healthcare, sleep therapy


Read Full Articlered right arrow icon